Go
View All
Randomised controlled trials (RCTs) of the use of long-acting injections (LAIs) in bipolar affective disorder
Rapid tranquillisation
Rating of Medication Influences (ROMI) scale
Readiness to change, influencing adherence
Recommendations for delayed maintenance dose of Ari 2MRTU
Recommendations for treatment for depression in multiple sclerosis (MS)
Recommendations for treatment of depression in Parkinson's disease (PD)
Recommendations for treatment of psychosis in Parkinson's disease (PD)
Recommendations for using psychotropics in atrial fibrillation (AF)
Recommendations to patients, adherence
Recommended actions in response to clozapine concentrations
Recommended drugs and drugs to avoid in dementia
Recommended drugs for rapid tranquillisation if the oral route is refused or has proven ineffective
Recommended ECG monitoring for people taking methadone
Recommended first-line treatments for acute mania
Recommended first-line treatments for bipolar depression
Recommended minimum effective doses of antidepressants
Recommended monitoring for diabetes in patients receiving antipsychotic drugs
Recommended psychotropics in renal impairment
Recommended treatment strategy fo rapid-cycling bipolar disorder
Rectal administration, antipsychotics
Recurrent depression, prophylaxis
Red blood count/red cell distribution width, psychotropic agent effects
Reduced hepatic blood flow; consequences of hepatic impairment
Reduction or discontinuation regimen for antipsychotic drugs in BPSD - a guide57,58
Displaying items 1 - 30 of 72